Trial intelligence / Profile preview

Danlou Tablets for myocardial injury in non-ST-elevation acute coronary syndrome patients undergoing PCI

ChiCTR-TRC-12001929Phase 4Completed

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Mar 2012
Countries
1
01

Overview

Phase 4 trial of danlou in acute coronary syndrome (ACS) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Cardiac troponin I, High-sensitivity C-reactive protein and 3 more. Started Mar 2012; status: completed.

02

Drugs

danlou
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on ChiCTR-TRC-12001929.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12001929.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call